image
Alnylam Pharmaceuticals, Inc. ALNY
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 235.56
-8.67 %
$ 30.4 B
Market Cap
-92.38
P/E
BALANCE SHEET
3.83 B ASSETS
7.99%
Growth Rates
1Year 7.99%
3Years 3.98%
5Years 19.45%
7Years 17.18%
10Years 24.72%
4.05 B LIABILITIES
9.34%
Growth Rates
1Year 9.34%
3Years 19.21%
5Years 71.52%
7Years 42.31%
10Years 39.02%
-221 M EQUITY
-39.45%
Growth Rates
1Year -39.45%
3Years -6.77%
5Years -3.18%
7Years -3.12%
10Years -6.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Alnylam Pharmaceuticals, Inc.
image
Current Assets 2.98 B
Cash & Short-Term Investments 2.44 B
Receivables 328 M
Other Current Assets 216 M
Non-Current Assets 847 M
Long-Term Investments 0
PP&E 726 M
Other Non-Current Assets 121 M
Current Liabilities 968 M
Accounts Payable 55.5 M
Short-Term Debt 96.5 M
Other Current Liabilities 816 M
Non-Current Liabilities 3.08 B
Long-Term Debt 2.59 B
Other Non-Current Liabilities 497 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
ASSETS
Cash & Cash Equivalents 812.7 866.4 820.0 496.6 547.2 420.1 645.4 193.6 1 281.0 881.9 53.2 51.4 70.2 74.6 137.5 191.8 105.2 128.0 15.8 20.3 23.2 15.5
Short Term Investments 1 626.7 1 326.0 1 615.6 1 377.8 989.0 664.0 1 045.3 433.2 51.4 94.6 192.7 71.4 76.2 158.5 143.9 238.6 350.4 89.3 64.2 25.8 0 0
Receivables 327.8 238.0 198.6 102.4 43.0 18.8 34.0 23.3 8.3 39.9 4.2 0.1 1.5 14.1 6.0 0 5.0 3.8 0.8 1.2 0 0
Inventory 89.1 129.0 122.7 92.3 56.3 24.1 1 1 1 0 1 0 (142.2) (226.2) 0 0 0 0 0 0 0 0
Other Current Assets 126.4 132.9 88.1 625.5 80.3 73.7 40.1 21.7 16.6 19.5 7.8 2.6 4.2 6.9 6.1 9.3 2.9 1.7 1.7 1.0 1.0 42 K
Total Current Assets 2 982.7 2 692.2 2 868.8 2 159.8 1 733.9 1 209.3 1 782.8 989.2 1 358.7 1 026.2 358.6 229.0 266.4 370.9 293.5 442.2 463.6 222.8 82.4 48.2 24.2 15.5
PP&E 725.8 738.6 733.6 706.5 646.4 320.7 181.9 114.6 27.8 21.7 16.4 19.8 14.6 18.3 18.3 19.2 13.8 12.2 10.6 11.7 4.8 0.5
Intangible Assets 697.8 264.6 0 0 0 0 0 0 0 0 0 0 0.3 0.4 0.6 0.8 1.0 1.9 2.5 3.4 3.9 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 (2 559.4) 40.9 40.7 14.8 44.8 30.0 9.0 251.8 279.8 45.5 38.7 0.6 3.6 6.4 1.6 0 0 0 0 0 0
Other Long Term Assets (576.4) 115.5 0 500.0 0 0 0 150.0 (251.8) 279.8 0 0 115.0 120.4 152.0 85.5 15.5 3.1 2.9 2.8 2.4 66 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 3 829.9 3 546.4 3 643.3 3 407.1 2 395.1 1 574.8 1 994.7 1 262.8 1 386.5 1 079.6 420.5 287.5 281.9 393.3 481.4 554.7 493.8 240.0 98.3 66.1 35.2 16.1
LIABILITIES
Accounts Payable 55.5 98.1 73.4 52.0 49.9 59.7 28.4 54.5 16.8 15.1 5.9 4.4 5.8 9.3 12.5 2.6 3.8 4.1 2.0 0.9 1.5 0.7
Short Term Debt 96.5 82.3 77.6 50.2 27.7 0 0 0 0 0 0 0 0 0 0 0 2.4 3.2 1.9 0.8 0.6 0
Other Current Liabilities 713.0 545.5 395.2 355.9 197.2 116.3 74.2 43.7 28.8 55.3 15.3 12.5 12.8 11.1 9.8 10.9 11.7 4.5 3.9 3.9 1.4 2.0
Total Current Liabilities 967.8 767.9 1 191.3 1 128.0 956.4 242.8 198.3 192.6 121.8 143.3 150.2 153.5 18.1 231.5 110.7 99.5 82.1 22.9 18.5 6.6 3.8 2.7
Long Term Debt 2 586.1 2 530.3 2 108.1 484.3 552.3 30.0 30.0 150.0 0 0 0 0 0 0 0 0 3.0 5.9 5.5 6.4 1.3 0
Deferred Tax Income 0 0 (152.4) (225.1) 0 (5.4) (47.4) (52.5) 0 31.7 0 0 0 0 0 0 (204.1) (6.8) (10.1) (4.1) 0 0
Other Liabilities 308.4 212.6 99.0 1 096.1 (266.8) 62.9 11.0 11.5 6.7 5.0 2.9 4.2 0.7 3.0 2.8 3.0 5.5 3.2 0 0 56.7 18.1
Total Liabilities 4 050.5 3 704.6 3 055.1 2 390.8 956.4 272.8 228.3 342.6 121.8 143.3 150.2 153.5 163.9 235.0 303.4 352.6 294.6 38.8 36.6 20.0 61.9 20.8
EQUITY
Common Stock 1.3 1.2 1.2 1.2 1.1 1.0 1.0 0.9 0.9 0.8 0.6 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.2 0 0
Retained Earnings (7 009.6) (6 569.3) (5 438.2) (4 585.4) (3 727.1) (2 841.0) (2 147.7) (1 656.8) (1 246.7) (956.6) (596.2) (507.0) (401.0) (343.3) (299.8) (252.2) (226.0) (140.5) (105.9) (63.0) (29.5) (4.5)
Other Accumulative Comprehensive Income/Loss (23.4) (44.7) (33.3) (43.6) (36.5) (33.2) (34.4) (33.4) 4.4 48.8 19.7 15.7 (0.2) 0.7 0.7 1.2 0.3 0.6 (2.6) (3.3) (4.6) (0.2)
Total Equity (220.6) (158.2) 588.2 1 016.2 1 438.7 1 302.0 1 766.4 920.2 1 264.7 936.3 270.3 134.1 118.0 158.2 178.0 202.1 199.2 201.2 61.8 46.1 (26.7) (4.6)
Total Liabilities and Equity 3 829.9 3 546.4 3 643.3 3 407.1 2 395.1 1 574.8 1 994.7 1 262.8 1 386.5 1 079.6 420.5 287.5 281.9 393.3 481.4 554.7 493.8 240.0 98.3 66.1 35.2 16.1
SHARES OUTSTANDING
Common Shares Outstanding 124.9 121.7 118.5 115.0 109.3 100.6 90.6 85.6 84.0 74.3 61.6 50.3 42.4 42.0 41.6 41.1 38.7 31.9 21.9 11.9 0.9 0.3